Specimen:
   Uterine corpus
   Cervix
   Right ovary
   Left ovary
   Right fallopian tube
   Left fallopian tube
   Left parametrium
   Right parametrium
   Vaginal cuff
   Omentum
   Other (specify):
   Not specified

Procedure:
   Supracervical hysterectomy
   Simple hysterectomy
   Radical hysterectomy
   Right oophorectomy
   Left oophorectomy
   Right salpingectomy
   Left salpingectomy
   Right salpingo-oophorectomy
   Left salpingo-oophorectomy
   Bilateral salpingo-oophorectomy
   Omentectomy
   Peritoneal biopsies
   Other (specify):
   Not specified

Lymph Node Sampling:
   Pelvic lymph nodes
   Para-aortic lymph nodes
   Other (specify):
   Not performed
   Not known

Specimen Integrity:
Morcellated hysterectomy specimen
Intact hysterectomy specimen

Tumor Site:
       Anterior endometrium
       Posterior endometrium
       Other (specify):

Tumor Size: cm

Histologic Type:
Endometrioid adenocarcinoma, not otherwise characterized
Endometrioid adenocarcinoma, variant (specify):
Mucinous adenocarcinoma
Serous adenocarcinoma
Clear cell adenocarcinoma
Mixed carcinoma (specify types and percentages):
Squamous cell carcinoma
Transitional cell carcinoma
Small cell carcinoma
Undifferentiated carcinoma
Carcinosarcoma (malignant müllerian mixed tumor)
Other (specify):

Histologic Grade:
International Federation of Gynecology and Obstetrics (FIGO) Grading System (applies to endometrioid and mucinous adenocarcinomas only):
    FIGO grade 1
    FIGO grade 2
    FIGO grade 3
For other carcinomas:
    G1: Well differentiated
    G2: Moderately differentiated
    G3: Poorly differentiated
Not applicable

Myometrial Invasion:
Not identified
Present:
       Depth of invasion: mm
       Myometrial thickness: mm
       <50% myometrial invasion
       ≥ 50% myometrial invasion
       Extent of myometrial invasion cannot be determined (see Comment)

Involvement of Cervix:
Not involved
Invasion of cervical stromal connective tissue
Cannot be determined (see Comment)

Extent of Involvement of Other Organs:
   Right ovary:
    Involved
    Not involved
    Not applicable
   Left ovary:
    Involved
    Not involved
    Not applicable
   Right fallopian tube:
    Involved
    Not involved
    Not applicable
   Left fallopian tube:
    Involved
    Not involved
    Not applicable
   Vagina:
    Involved
    Not involved
    Not applicable
   Right parametrium:
    Involved
    Not involved
    Not applicable
   Left parametrium:
    Involved
    Not involved
    Not applicable
   Omentum:
    Involved
    Not involved
    Not applicable
   Rectal wall:
    Involved
    Not involved
    Not applicable
   Bladder wall:
    Involved
    Not involved
    Not applicable
   Pelvic wall:
    Involved
    Not involved
    Not applicable
   Bladder mucosa and/or bowel mucosa:
    Involved
    Not involved
    Not applicable
   Other (specify):

Peritoneal Ascitic Fluid:
    Negative for malignancy/normal/benign
    Atypical and/or suspicious:
    Malignant (positive for malignancy)
    Unsatisfactory/nondiagnostic:

Margins:
Cannot be assessed
Uninvolved by invasive carcinoma, closest margin mm at
Involved by invasive carcinoma:

Lymph-Vascular Invasion:
Not identified
Present
Indeterminate

Pathologic Staging (pTNM (FIGO))

m (multiple primary tumors)
r (recurrent)
y (post-treatment)

Primary Tumor (pT):
pTX (--): Primary tumor cannot be assessed
pT0 (--): No evidence of primary tumor
pT1a (IA): Tumor limited to endometrium or invades less than one-half of the myometrium
pT1b (IB): Tumor invades greater than or equal to one-half of the myometrium
pT2 (II): Tumor invades stromal connective tissue of the cervix, but does not extend beyond uterus
pT3a (IIIA): Tumor involves serosa and/or adnexa (direct extension or metastasis)
pT3b (IIIB): Vaginal involvement (direct extension or metastasis) or parametrial involvement
pT4 (IVA): Tumor invades bladder mucosa and/or bowel mucosa (bullous edema is not sufficient to classify a tumor as T4)

Regional Lymph Nodes (pN):
pNX: Cannot be assessed
pN0: No regional lymph node metastasis
pN1 (IIIC1): Regional lymph node metastasis to pelvic lymph nodes
pN2 (IIIC2): Regional lymph node metastasis to para-aortic lymph nodes, with or without positive pelvic lymph nodes

Pelvic lymph nodes:
   No nodes submitted or found
   Number of Lymph Nodes Examined:
   Number of Lymph Nodes Involved:

Para-aortic lymph nodes:
   No nodes submitted or found
   Number of Lymph Nodes Examined:
   Number of Lymph Nodes Involved:

Distant Metastasis (pM):
    Not applicable
    pM1 (IVB): Distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, or lung, liver, or bone metastasis. It excludes metastasis to para-aortic lymph nodes, vagina, pelvic serosa, or adnexa):

Additional Pathologic Findings:
       None identified
       Hyperplasia:
        Simple without cytologic atypia
        Complex without cytologic atypia
       Atypical hyperplasia:
        Simple
        Complex
       Endometrial intraepithelial neoplasia (EIN)
       Other (specify):

Ancillary Studies:

Clinical History:
       Lynch syndrome
       Other (specify):

Comment(s):